Briefly, studies related to SCC, BCC, breast cancer, cervical cancer, colon cancer, lung cancer, multiple myeloma, and ovarian cancer are predominantly associated with a pro-tumorigenic function for DSG2. This evidence concerns the gene DSG2 and breast carcinoma.